Literature DB >> 32356934

Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data.

M N Bekker1, L Henneman2, M V E Macville3, E A Sistermans2, R J H Galjaard4.   

Abstract

Year:  2020        PMID： 32356934     DOI： 10.1002/uog.22030

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN： 0960-7692            Impact factor:   7.299


× No keyword cloud information.
  2 in total

1.  Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.

Authors:  Lisanne van Prooyen Schuurman; Erik A Sistermans; Diane Van Opstal; Lidewij Henneman; Mireille N Bekker; Caroline J Bax; Mijntje J Pieters; Katelijne Bouman; Sonja de Munnik; Nicolette S den Hollander; Karin E M Diderich; Brigitte H W Faas; Ilse Feenstra; Attie T J I Go; Mariëtte J V Hoffer; Marieke Joosten; Fenne L Komdeur; Klaske D Lichtenbelt; Maria P Lombardi; Marike G Polak; Fernanda S Jehee; Heleen Schuring-Blom; Servi J C Stevens; Malgorzata I Srebniak; Ron F Suijkerbuijk; Gita M Tan-Sindhunata; Karuna R M van der Meij; Merel C van Maarle; Vivian Vernimmen; Shama L van Zelderen-Bhola; Nicolien T van Ravesteyn; Maarten F C M Knapen; Merryn V E Macville; Robert-Jan H Galjaard
Journal:  Am J Hum Genet       Date:  2022-06-02       Impact factor: 11.043

2.  Confined placental mosaicism of trisomy 6 detected through genome-wide NIPT was associated with placental abruption.

Authors:  Miyuki Nishiyama; Seiji Wada; Fuyuki Hasegawa; Yohji Uehara; Mamoru Ozaki; Kenichiro Hata; Yushi Ito; Haruhiko Sago
Journal:  Clin Case Rep       Date:  2021-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.